SAHPRA cautions the public to not purchase and/or consume such products as their safety, efficacy, and quality have not been ...
These pose a health risk to the public. Sahpra cautions the public to not purchase and/or consume such products as their ...
“Novo Nordisk does not promote, suggest, or encourage off-label use, or misuse, or any of our medications,” a spokesperson ...
Lars Fruergaard Jørgensen began his career at Novo Nordisk as an economist in the health care, economy, and planning ...
The SA Health Products Regulatory Authority has expressed concern at the increasing presence of counterfeit products such as ...
While semaglutide remains on the shortage list, Novo Nordisk noted last week that the last remaining ... and that counterfeit forms of Ozempic are being sold. Semaglutide and a similar GLP-1 drug, ...
Are you a print subscriber? Activate your account. By Garett Sloane - 3 min 8 sec ago By Ewan Larkin - 8 min 31 sec ago By ...
Novo Nordisk’s dominance in the obesity and diabetes markets, already bolstered by the success of Wegovy and Ozempic, could be further strengthened if CagriSema lives up to expectations. Obesity ...